发明名称 S1P3 RECEPTOR ANTAGONIST
摘要 FIELD: chemistry. ^ SUBSTANCE: invention relates to novel compounds - arylamidrazone derivatives of formula , ^ where R1 is a C2-C8 alkyl group or a C2-C8 alkoxy group, which can be substituted with a halogen or a C1-C8 alkoxy group; a 5-7-member aromatic heterocycle containing 1 or 2 oxygen, nitrogen or sulphur atoms, or phenyl, which can be substituted with a halogen, a C1-C8 alkyl group, a haloC1-C8alkyl group or a C1-C8alkoxy group; or NR4R5; R2 and R3 are identical or different, and each is a hydrogen atom, a halogen atom, a halogenC1-C8alkyl group, a C1-C8alkyl group, a C2-C6alkynyl group, a C1-C8alkoxy group, a cyano group, a C2-C6alkanoyl group or a C1-C8alkylsulphonyl group; A is a benzene, pyridine, quinoline or isoquinoline ring; D is a single bond or methylene; m assumes values from 1 to 3 and n assumes values from 1 to 5, having antagonistic effect on S1P3 receptors, as well as to medicinal agents and pharmaceutical compositions containing such compounds as an active ingredient. ^ EFFECT: improved properties. ^ 13 cl, 161 ex, 19 tbl
申请公布号 RU2424227(C2) 申请公布日期 2011.07.20
申请号 RU20080118201 申请日期 2006.10.11
申请人 TOA EHJO LTD. 发明人 OKHNUMA SIN-JA;KHASEGAVA TAKESI;SADA TOMOJUKI
分类号 A61K31/155;A61K31/277;A61K31/33;A61K31/445;A61P7/02;A61P9/00;A61P11/00;A61P13/00;A61P13/12;A61P27/02;A61P35/00;A61P43/00;C07C257/22;C07C317/36;C07D295/18;C07D307/46;C07D333/22 主分类号 A61K31/155
代理机构 代理人
主权项
地址